Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshikane Kikushige

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Cancer Science|June 23, 2021
TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathwaysYoshikane Kikushige
Journal of Clinical and Experimental Hematopathology : JCEH|November 5, 2020
Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategiesYoshikane Kikushige
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Molecular targeted therapy for leukemic stem cells]Yoshikane Kikushige
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression]Yoshikane Kikushige
Blood Cell Therapy|May 23, 2023
Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapyYoshikane Kikushige
International Journal of Hematology|December 5, 2019
Pathophysiology of chronic lymphocytic leukemia and human B1 cell developmentYoshikane Kikushige
International Journal of Hematology|August 8, 2014
Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesisYoshikane Kikushige, Toshihiro Miyamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Cytotoxic chemotherapy for AML in adults]Toshihiro Miyamoto, Yoshikane Kikushige
International Journal of Hematology|February 4, 2015
Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemiaYoshikane Kikushige, Toshihiro Miyamoto
Oncology|November 10, 2015
Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid LeukemiaYoshikane Kikushige, Toshihiro Miyamoto
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Cancer Science|June 23, 2021
TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathwaysYoshikane Kikushige
Journal of Clinical and Experimental Hematopathology : JCEH|November 5, 2020
Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategiesYoshikane Kikushige
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Molecular targeted therapy for leukemic stem cells]Yoshikane Kikushige
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression]Yoshikane Kikushige
Blood Cell Therapy|May 23, 2023
Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapyYoshikane Kikushige
International Journal of Hematology|December 5, 2019
Pathophysiology of chronic lymphocytic leukemia and human B1 cell developmentYoshikane Kikushige
International Journal of Hematology|August 8, 2014
Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesisYoshikane Kikushige, Toshihiro Miyamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Cytotoxic chemotherapy for AML in adults]Toshihiro Miyamoto, Yoshikane Kikushige
International Journal of Hematology|February 4, 2015
Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemiaYoshikane Kikushige, Toshihiro Miyamoto
Oncology|November 10, 2015
Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid LeukemiaYoshikane Kikushige, Toshihiro Miyamoto
Pageof 8